Guided Therapeutics (GTHP) Non Operating Income (2015 - 2025)
Guided Therapeutics recorded quarterly Non Operating Income of -$508000.0 in Q4 2025, down 97.67% quarter-over-quarter from -$257000.0 in Q3 2025, and down 330.51% year-over-year from $220382.4 in Q4 2024.
Guided Therapeutics' Non Operating Income history runs 11 years deep, the most recent figure standing at -$508000.0 for Q4 2025.
- In Q4 2025, Non Operating Income fell 330.51% year-over-year to -$508000.0; the TTM figure through Dec 2025 stood at -$715000.0 (down 261.11% YoY), while the FY2025 annual figure was -$824000.0, down 166.67% from the prior year.
- Non Operating Income came in at -$508000.0 for Q4 2025 at Guided Therapeutics, down from -$257000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $555000.0 in Q3 2021 to a low of -$508000.0 in Q4 2025.
- A 5-year average of -$57555.6 and a median of -$50000.0 in 2023 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income slumped 2800.0% in 2023 and soared 9700.0% in 2025, its largest moves.
- Guided Therapeutics' Non Operating Income stood at -$9000.0 in 2021, then jumped by 222.22% to $11000.0 in 2022, then jumped by 1445.45% to $170000.0 in 2023, then plunged by 169.41% to -$118000.0 in 2024, then plunged by 330.51% to -$508000.0 in 2025.
- According to Business Quant data, Non Operating Income over the past three periods registered -$508000.0, -$257000.0, and -$48000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 159.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 121.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 61.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 71.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 14.20 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 36.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.80 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -508,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -508,000.00 |
| Sep 30, 2025 | -257,000.00 |
| Jun 30, 2025 | -48,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Dec 31, 2024 | -118,000.00 |
| Sep 30, 2024 | -93,000.00 |
| Jun 30, 2024 | 12,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 170,000.00 |
| Sep 30, 2023 | -54,000.00 |
| Jun 30, 2023 | -52,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | -209,000.00 |
| Mar 31, 2022 | -64,000.00 |
| Dec 31, 2021 | -9,000.00 |
| Sep 30, 2021 | 555,000.00 |
| Jun 30, 2021 | -473,000.00 |
| Dec 31, 2020 | 2.45 Mn |
| Sep 30, 2020 | 1.73 Mn |
| Jun 30, 2020 | -6.38 Mn |
| Mar 31, 2020 | 2.97 Mn |
| Dec 31, 2019 | 1.25 Mn |
| Sep 30, 2019 | 62,000.00 |
| Jun 30, 2019 | -2.34 Mn |
| Mar 31, 2019 | 42,000.00 |
| Dec 31, 2018 | -2.29 Mn |
| Sep 30, 2018 | -512,000.00 |
| Jun 30, 2018 | 3.91 Mn |
| Mar 31, 2018 | 1.08 Mn |
| Dec 31, 2017 | -4.03 Mn |
| Sep 30, 2017 | -1.03 Mn |
| Jun 30, 2017 | -538,000.00 |
| Mar 31, 2017 | 407,000.00 |
| Dec 31, 2016 | -896,000.00 |
| Sep 30, 2016 | 468,000.00 |
| Jun 30, 2016 | -981,000.00 |
| Mar 31, 2016 | 1.26 Mn |
| Dec 31, 2015 | -214,000.00 |
| Sep 30, 2015 | -353,000.00 |